Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;36(8):2333-9.
doi: 10.1016/j.neurobiolaging.2015.04.001. Epub 2015 Apr 4.

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

Affiliations

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

Susan M Resnick et al. Neurobiol Aging. 2015 Aug.

Abstract

Apolipoprotein E (APOE) genotype influences onset age of Alzheimer's disease but effects on disease progression are less clear. We investigated amyloid-β (Aβ) levels and change in relationship to APOE genotype, using 2 different measures of Aβ in 2 different longitudinal cohorts. Aβ accumulation was measured using positron emission tomography (PET) imaging and (11)C-Pittsburgh compound-B (PiB) in 113 Baltimore Longitudinal Study of Aging participants (mean age 77.3 years; 107 normal, 6 cognitively impaired) and cerebral spinal fluid (CSF) Aβ1-42 assays in 207 BIOCARD study participants (mean age 62 years; 195 normal, 12 cognitively impaired). Participants in both cohorts had up to 7 serial assessments (mean 2.3-2.4). PET-PiB retention increased and CSF Aβ1-42 declined longitudinally. APOE ε4 was significantly associated with higher PET-PiB retention and lower CSF Aβ1-42, independent of age and sex, but APOE genotype did not significantly affect Aβ change over time. APOE ε4 carriers may be further along in the disease process, consistent with earlier brain Aβ deposition and providing a biological basis for APOE genotype effects on onset age of Alzheimer's disease.

Keywords: Apolipoprotein E genotype; Biomarkers; CSF Aβ(1-42); Longitudinal; PET amyloid imaging.

PubMed Disclaimer

Conflict of interest statement

The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.

Figures

Figure 1
Figure 1
Observed values of Aβ over time for (a) PET-PiB mean cortical DVR (cDVR) and (b) CSF Aβ1–42. Within-individual changes are shown by connecting lines. Individuals who are cognitively normal at baseline evaluation are shown in black, mild cognitive impairment (MCI) and Alzheimer disease in red, and “cognitively impaired, not MCI” in blue. Threshold for detection of elevated PiB retention is shown as a gray line in (a).
Figure 2
Figure 2
Observed values of Aβ over time stratified by APOE ε4 carrier status for (a) PET-PiB mean cortical DVR (cDVR) and (b) CSF Aβ1–42. Within-individual changes are shown by connecting lines. APOE ε4 negative individuals are shown in black and APOE ε4 positive in red. Threshold for detection of elevated PiB retention is shown as a gray line in (a).
Figure 3
Figure 3
Cross-sectional effect of age on (a) PET-PiB mean cortical DVR (cDVR) and (b) CSF Aβ1–42, showing stronger association of age with Aβ for APOE ε4 carriers compared with non-carriers. This interaction reached significance for PET-PiB (p = 0.047) and was at trend level for CSF Aβ1–42 (p = 0.076).

Similar articles

Cited by

References

    1. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC Cache County Study I. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Arch Gen Psychiatry. 2004 May;61(5):518–524. - PubMed
    1. Slooter AJ, Houwing-Duistermaat JJ, van Harskamp F, et al. Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam Study. J Neurol. 1999 Apr;246(4):304–308. - PubMed
    1. Bracco L, Piccini C, Baccini M, et al. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Dement Geriatr Cogn Disord. 2007;24(6):483–491. - PubMed
    1. Martins CA, Oulhaj A, de Jager CA, Williams JH. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology. 2005 Dec 27;65(12):1888–1893. - PubMed
    1. Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of aging. 2010 Aug;31(8):1275–1283. - PubMed

Publication types

MeSH terms